- Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
- Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
- Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
- Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
- Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
More ▼
Key statistics
On Friday, Co-Diagnostics Inc (CODX:NAQ) closed at 1.25, 27.41% above the 52 week low of 0.9811 set on Oct 04, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.27 |
---|---|
High | 1.31 |
Low | 1.22 |
Bid | 1.22 |
Offer | 1.40 |
Previous close | 1.28 |
Average volume | 100.59k |
---|---|
Shares outstanding | 31.28m |
Free float | 30.15m |
P/E (TTM) | -- |
Market cap | 40.04m USD |
EPS (TTM) | -1.32 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼